# 1. Financial Performance ## A. Key Figures * **Revenue:** **₹623 Cr** Q3FY26 (+~19%) · **₹2,441 Cr** 9MFY26 (+9%) * **EBITDA:** **₹58 Cr** Q3FY26 (+29%) * **PAT:** **₹2 Cr** Q3FY26 (–81%) * **Cash Balance:** **₹455 Cr** as of Dec 31 ## B. Revenue Growth * **Strong Volume-Led Growth:** Revenue expansion driven by **~28% volume growth**, offsetting **~8% pricing de-growth**, reflecting resilient demand despite unseasonal rains and crop damage. * **B2B Outpaces B2C:** B2B revenue surged on **22% growth** from expanded customer base, while B2C rose modestly at **3%**. * **Crop Care Anchors Performance:** Crop Care segment delivered **8% growth** on volume strength, contributing ₹1,991 crore to 9M revenue. ## C. EBITDA & Profit * **EBITDA Margin Expansion:** EBITDA grew **29%** with **blended gross margin sustained at ~30%**, indicating effective cost control amid pricing pressure. * **PAT Impact from Non-Recurring Charge:** Sharp decline in profit after tax due to **₹40 Cr exceptional gratuity provision**; underlying earnings remain robust. ## D. Cash Flow * **Healthy Liquidity Position:** Elevated inventory levels managed with smooth collections, maintaining a **strong cash balance of ₹455 Cr**. * **Strategic Cash Deployment:** Cash reserves provide pricing leverage and are earmarked for **inorganic opportunities** across three core verticals. --- # 2. Segment & Product Performance ## A. Key Figures * **Crop Care Revenue:** **₹580 Cr** (+18%) * Seeds Revenue: ₹43 Cr (+46%) · ₹450 Cr 9M (+15%) * **Soil & Plant Health Revenue:** **₹73 Cr** (+16%) * **CSM Revenue:** **₹46 Cr** (+26% QoQ) ## B. Crop Care Performance * **Volume-Driven Expansion:** Crop Care growth fueled by customer base expansion, digital engagement, and new product rollouts, supported by portfolio optimization and cost discipline. * **Strategic Focus:** Digital-led targeting and market penetration enhanced through rationalized territories and concentrated priority market focus. * **Rabi Season Dynamics:** Overall improvement in Rabi performance year-on-year, with strong results in potato and cumin fungicides, while area declines in grape and cumin challenged some portfolios. ## C. Seeds Business Momentum * **Robust Growth Trajectory:** Seeds segment delivered strong revenue growth with solid volume gains in paddy, mustard, wheat, cotton, and maize, aided by successful product placements and licensed offerings. * **Strategic Crop Focus:** Expansion centered on five key crops—Cotton, Maize, Millet, Mustard, and Rice—to build scale, efficiency, and profitability with methodical market rollout. * **Innovation Pipeline:** Growth expected to be chunky, driven by recent launches in maize, rice, and bajra, building on North cotton hybrid success and advanced biotech traits. * **Margin Recovery:** Business showed reduced losses and high-margin characteristics, with management targeting full-year margins near **25%**. ## D. Soil & Plant Health * **Sustainable Solutions Push:** Launch of **NuCode**, a dedicated biologicals platform (bio-fertilizers, bio-stimulants, bio-pesticides), signals strategic shift toward sustainable agriculture. * **Dual Growth Drivers:** Revenue growth supported by both price and volume, underpinned by in-house bio-stimulant production and improved compliance across states. * **Brand & Traction:** NuCode brand launched with strong early traction; seed and Crop Care teams operate independently. ## E. CSM Segment & Innovation * **High-Margin Niche Growth:** CSM delivered strong quarterly growth on a small base, operating at **~13% margin** in B2C domestic and B2B export markets, competing with Chinese players while maintaining domestic brand premium. * **Innovation Ecosystem:** Launched **Idea2Impact** open-innovation platform and **Sampark Plus** unified field app to co-create and scale farmer-centric solutions, leveraging brand trust. * **Technology & IP Gains:** Secured Indian patent for a **three-way herbicide combo** in wheat and US patent for **Mesotrione process**, enhancing technical differentiation. * **Growth Levers:** Focus on reducing raw material costs, improving realizations, and expanding domestic institutional sales of AIs; new patented products seen as key to gaining high-value contracts. * **Partnership Pipeline:** Active engagement with partners including **Paryan Alliance** for FullPage® herbicide-tolerant rice tech; early-stage CSM opportunities expected to contribute from FY27. --- # 3. Volume & Pricing Trends ## A. Key Figures * **Domestic B2C Revenue:** **₹391 Cr** (+13%) · **₹347 Cr** prior year * **Volume Growth (B2C):** **+25%** (positive impact) · **Price Impact:** **–12%** (negative) * **Rabi Acreage Growth:** **~3% YoY** (wheat, oilseeds, pulses) * **Product Launches (9M FY26):** **9 new products** (7 herbicides, 2 fungicides) * **Financial Impact (Delay):** **>₹10 Cr** loss from insecticide launch delay ## B. Domestic B2C Mix * **Regional Demand Divergence:** Farmer demand weakened sharply in South and West India, while North and East remained stable amid broader agrochemical sentiment shift. * **Crop Economics Pressure:** All kharif crops except paddy traded below MSP in late 2025, weighing on farmer sentiment and input spending capacity. * **Strong Volume Momentum:** B2C segment delivered robust double-digit revenue growth on **25% volume expansion**, led by fungicides for potato and cumin. * **Pricing Headwinds:** Revenue growth partially offset by negative pricing due to near-expiry product liquidation, reflecting tactical inventory management. * **Q4 & Kharif Outlook:** Elevated channel stocks and early rabi planting support sell-out momentum and advance kharif supply placement, especially in cotton-growing regions. ## C. Export Realizations * **Latin America Crop Price Softening:** Corn and soybean price declines in key export markets are under close watch, signaling potential demand risks ahead. ## D. Product Launch Effect * **Active Portfolio Expansion:** Successful launch of **'Fateh Nxt'** herbicide and **8 other products** in 9M FY26 reinforces market share growth strategy. * **Launch Disruption:** Insecticide launch delayed due to **factory quality issues**, resulting in **over ₹10 Cr** in financial impact, highlighting execution risk in new product rollouts. --- # 4. Capacity & Utilization ## A. Plant Utilization * **Headline:** Significant improvement in plant and capacity utilization across all facilities, enhancing operational efficiency and scalability. * **Headline:** Sufficient inventory has been secured for BigHaat and crop operations in FY26, resolving prior supply constraints. ## B. Capex Plans * **Headline:** No major capex planned without firm contract backing; growth to be supported by existing infrastructure. * **Headline:** Only sustainable, maintenance-level capex expected going forward, reflecting disciplined capital allocation. --- # 5. Export & Geography Mix ## A. Key Figures * **Exports (B2B) Revenue:** **₹129 Cr** (+73% YoY) * **Export Business Growth:** **73%** (Seeds +46%, Soil & Plant Health +16%, Domestic Crop Protection +13%) * **Export Margin:** **>20%** despite competitive pressures ## B. B2B Export Growth * **Robust Export Rebound:** B2B export revenue surged on strong volume growth, expanded customer base, and higher capacity utilization, outpacing domestic crop protection. * **Margin Resilience:** Export margins exceeded 20% despite pricing pressures from global inventory normalization and increased Chinese supply. * **Product & Trade Dynamics:** Key exports include acephate, metribuzin, hexaconazole, and metalaxyl; U.S. anti-dumping duties on 2,4-D and China’s VAT rebate removal are reshaping trade flows. ## C. Global Market Access * **Strategic International Expansion:** Company is building on-ground teams to accelerate registrations, partnerships, and customer acquisition in key geographies. * **Growth Tailwinds:** Expanding acreage in the Americas and potential EU regulatory clarity on NGTs support long-term demand. ## D. China Dependence * **Persistent Supply Reliance:** Blended technical procurement from China remains above **40%**, with no plans for full de-risking due to complexity and lifecycle constraints. * **Pricing & Geopolitical Risks:** Chinese oversupply continues to depress global prices, while rapid price resets in key technicals pose margin risks; new geopolitical developments under active assessment. --- # 6. Regulatory & Supply Risks ## A. China Policy Risk * **Weak Domestic Demand:** Agrochemical demand remains subdued due to adverse weather and low crop prices, contributing to industry-wide volume declines. * **Intensifying Competitive Pressure:** Chinese producers are advancing into branded formulations and overseas markets, increasing competition in value-added generics for Indian players. * **Neutral Impact from Export Rebate Changes:** Anticipated removal of China’s export rebates post-April is expected to affect all market participants equally, posing no material disadvantage. * **Production Trends Normalizing:** Despite reported year-on-year increases in Chinese technical production, inventory levels are currently normalized, suggesting no immediate oversupply risk. ## B. Agrochemical Regulation * **Favorable Climate Outlook:** ENSO is forecast to remain neutral through DJF 2026, and weakening negative IOD reduces likelihood of disruptive weather events. * **Structural Advantage from New Regulations:** The Draft Pesticides Management Bill, 2025 and proposed Seeds Bill introduce quality controls, digital traceability, and stricter compliance, benefiting organized players and raising entry barriers. * **Regulatory Transition Complete:** Company has successfully migrated operations to meet new standards, including resolution of biostimulant-specific challenges, and is largely past major biofertilizer regulatory hurdles. * **Consolidation in Unorganized Segment:** Fragmented soil and plant health market is undergoing consolidation, with inauthentic players being replaced by organized, compliant entities. ## C. Supply Chain Exposure * **China-Dependent Global Supply:** Critical agrochemicals like glyphosate, glufosinate, and atrazine remain heavily reliant on Chinese production, creating vulnerability to policy and tariff shifts. * **Resilient Inventory Dynamics:** Market-held inventory is being actively consumed with ongoing replenishment supported by persistent agricultural demand, including in the Eastern region. * **Kharif Season Disruptions:** Excessive rainfall in August–September led to missed sprays, particularly impacting soybean and cotton herbicide performance. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Aspiration:** **Double-digit growth** over 5 years * **EBITDA Margin Target:** **+500 bps** over 5 years * **Seed Business Target:** **₹1,000 Cr** in 5 years * **Soil & Plant Health Target:** **₹700–800 Cr** in 5 years (from ₹225 Cr) ## B. Revenue Aspirations * **Seasonal Resilience:** Q4 demand expected to follow normal crop-linked patterns, insulated from potential Chinese dumping pressures. * **International Uncertainty:** No formal guidance for international business due to volatile **tariff policies and geopolitical dynamics**. * **CSM Growth Strategy:** Expansion to be driven by **niché, high-value contracts** rather than broad market penetration; no specific revenue targets disclosed. ## C. Margin Expansion * **Stable-to-Soft Near-Term Margins:** Global pricing pressure and competition likely to constrain margin movement despite volume tailwinds from **higher acreage and improved moisture**. * **Long-Term EBITDA Leverage:** Targeted 500 bps EBITDA margin expansion driven primarily by **operating leverage**, underpinned by controlled R&D and a scalable team. ## D. Strategic Growth Targets * **Positive Near-Term Outlook:** Supported by strong reservoir levels, rising acreages, and enhanced customer engagement across domestic and export markets. * **Growth Enablers:** Strategy centered on **faster product launches, digital integration, strategic alliances, and expanded farmer reach** to capture high-margin opportunities. * **Capital Allocation:** Balance sheet cash maintained to fund working capital needs arising from growth initiatives.